Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 212385
Company: P AND L DEVELOPMENT
Company: P AND L DEVELOPMENT
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
DOCOSANOL | DOCOSANOL | 10% | CREAM;TOPICAL | Over-the-counter | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
10/07/2022 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
DOCOSANOL
The products listed here are over-the-counter (OTC) drugs and do not receive therapeutic equivalence ratings. They may not be interchangeable.
CREAM;TOPICAL; 10%
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | Application No. | Company |
---|---|---|---|---|---|---|---|
ABREVA | DOCOSANOL | 10% | CREAM;TOPICAL | Over-the-counter | Yes | 020941 | HALEON US HOLDINGS |
DOCOSANOL | DOCOSANOL | 10% | CREAM;TOPICAL | Over-the-counter | No | 215839 | ALEMBIC |
DOCOSANOL | DOCOSANOL | 10% | CREAM;TOPICAL | Over-the-counter | No | 217090 | AUROBINDO PHARMA LTD |
DOCOSANOL | DOCOSANOL | 10% | CREAM;TOPICAL | Over-the-counter | No | 208754 | P AND L |
DOCOSANOL | DOCOSANOL | 10% | CREAM;TOPICAL | Over-the-counter | No | 212385 | P AND L DEVELOPMENT |
DOCOSANOL | DOCOSANOL | 10% | CREAM;TOPICAL | Over-the-counter | No | 214454 | TARO |